Omeros Corporation OMER was a big mover last session, as the company saw its shares rise almost 12% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $14.95 to $16.44 in the past one-month time frame.
The company has seen two negative estimate revisions in the last 30 days and the Zacks Consensus Estimate also moved lower suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher can last.
Currently, Omeros carries a Zacks Rank #3 (Hold).
A better-ranked stock in the same industry is Bio-Rad Laboratories, Inc. BIO, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.
Is OMER going up? Or down? Predict to see what others think: Up or Down
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time. One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>
Bio-Rad Laboratories, Inc. BIO: Free Stock Analysis Report
Omeros Corporation OMER: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
